Also, our work in pancreatic ductal adenocarcinoma (PDAC) murine models demonstrated that PDP can prime multiple tumor compartments to enable a more potent and sustained antitumor chemotherapeutic effect [20] or chemotherapy dose reduction for improved tolerability [22]. The gene discussed is PDP1; the disease is neoplasm.